Delivery Order SPE2DB20D1100-SPE2DB24FA0D5

Award Date 2/1/24
Potential Completion Date 2/2/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,491,701 units of the pharmaceutical product VELTASSA 8.4 GM POWDER PACKET 30S. The contract has a potential value of $1,370.30 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which is not associated with any...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563895173 VELTASSA 8.4 GM POWDER PACKET 30S. The contract has a completion date of March 8, 2024 and a potential value of $9,153.96. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) awarded by DLA with...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation. The $5,324.91 contract is for the provision of VELTASSA 8.4 GM POWDER PACKET 30S, a pharmaceutical product, with a completion date of March 1, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the medical supplies from its facility in Conshohocken, Pennsylvania. This delivery order is...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distributor. The order is for VELTASSA 8.4 GM POWDER PACKET 30S, a pharmaceutical product, with a potential value of $2,582.20 and a completion date of February 29, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,417,400 units of the pharmaceutical product VELTASSA 8.4 GM POWDER PACKET 30S. The $4,732.02 award has a completion date of January 24, 2024. As a prime contractor, AmerisourceBergen Drug Corp has a history of providing pharmaceutical products and medical supplies to support Department of Defense...
This is a $1,057.81 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VELTASSA 8.4 GM POWDER PACKET 30S. The order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order has a completion date of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VELTASSA 8.4 GM POWDER PACKETS. The contract has a total ceiling value of $1,936.65 and runs through May 6, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VELTASSA 8.4 GM POWDER PACKET 30S pharmaceutical product. The $2,086.17 order has a completion date of January 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides a range of pharmaceutical products and medical supplies to support DLA Troop Support Medical...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,793.03, is for the procurement of VELTASSA 8.4 GM POWDER PACKET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 4, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The contract is for the supply of VELTASSA 8.4 GM POWDER PACKET 30S, a specialty pharmaceutical product, with a potential value of $6,209.27 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA0D5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VELTASSA 8.4 GM POWDER PACKET 30S, a pharmaceutical product, with a potential value of $1,291.10 and a performance period through February 2, 2024. This delivery order is issued under an indefinite delivery contract (IDC) that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The IDC does not have any set-aside designations and was awarded solely to Amerisourcebergen Drug Corp as a single award contract with a potential value of up to $999,999,999.00 through December 31, 2025.

Generated 5/2/24, 11:19 AM